Nevro Share Holder Equity 2013-2024 | NVRO
Nevro share holder equity from 2013 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
| Nevro Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023 | $293 |
| 2022 | $324 |
| 2021 | $304 |
| 2020 | $388 |
| 2019 | $216 |
| 2018 | $245 |
| 2017 | $249 |
| 2016 | $249 |
| 2015 | $235 |
| 2014 | $172 |
| 2013 | $67 |
| 2012 | $44 |
| Nevro Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024-09-30 | $274 |
| 2024-06-30 | $274 |
| 2024-03-31 | $279 |
| 2023-12-31 | $293 |
| 2023-09-30 | $286 |
| 2023-06-30 | $295 |
| 2023-03-31 | $301 |
| 2022-12-31 | $324 |
| 2022-09-30 | $325 |
| 2022-06-30 | $230 |
| 2022-03-31 | $240 |
| 2021-12-31 | $304 |
| 2021-09-30 | $319 |
| 2021-06-30 | $358 |
| 2021-03-31 | $366 |
| 2020-12-31 | $388 |
| 2020-09-30 | $380 |
| 2020-06-30 | $374 |
| 2020-03-31 | $215 |
| 2019-12-31 | $216 |
| 2019-09-30 | $198 |
| 2019-06-30 | $202 |
| 2019-03-31 | $214 |
| 2018-12-31 | $245 |
| 2018-09-30 | $244 |
| 2018-06-30 | $246 |
| 2018-03-31 | $243 |
| 2017-12-31 | $249 |
| 2017-09-30 | $244 |
| 2017-06-30 | $241 |
| 2017-03-31 | $243 |
| 2016-12-31 | $249 |
| 2016-09-30 | $248 |
| 2016-06-30 | $246 |
| 2016-03-31 | $229 |
| 2015-12-31 | $235 |
| 2015-09-30 | $244 |
| 2015-06-30 | $262 |
| 2015-03-31 | $159 |
| 2014-12-31 | $172 |
| 2014-09-30 | $47 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | |
| 2013-09-30 | $0 |
| 2012-12-31 | $44 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.214B | $0.425B |
| Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $219.062B | 26.20 |
| Intuitive Surgical (ISRG) | United States | $209.612B | 96.16 |
| Alcon (ALC) | Switzerland | $45.206B | 30.25 |
| Edwards Lifesciences (EW) | United States | $41.870B | 26.59 |
| IQVIA Holdings (IQV) | United States | $38.108B | 20.48 |
| IDEXX Laboratories (IDXX) | United States | $37.713B | 43.16 |
| DexCom (DXCM) | United States | $34.497B | 51.95 |
| Mettler-Toledo (MTD) | United States | $28.642B | 32.97 |
| Waters (WAT) | United States | $24.401B | 36.08 |
| STERIS (STE) | Ireland | $22.253B | 25.33 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.160B | 0.00 |
| Hologic (HOLX) | United States | $14.774B | 15.85 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.260B | 14.64 |
| Globus Medical (GMED) | United States | $11.976B | 30.33 |
| Sysmex ADR (SSMXY) | Japan | $11.771B | 36.91 |
| Penumbra (PEN) | United States | $10.036B | 98.31 |
| Masimo (MASI) | United States | $9.638B | 46.64 |
| Glaukos (GKOS) | United States | $8.562B | 0.00 |
| Teleflex (TFX) | United States | $8.064B | 12.86 |
| Integer Holdings (ITGR) | United States | $4.726B | 26.79 |
| Inari Medical (NARI) | United States | $4.676B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.694B | 0.00 |
| Veracyte (VCYT) | United States | $3.371B | 101.16 |
| Nihon Kohden (NHNKY) | Japan | $2.700B | 14.76 |
| LivaNova (LIVN) | United Kingdom | $2.605B | 15.04 |
| TransMedics (TMDX) | United States | $2.467B | 78.19 |
| Tandem Diabetes Care (TNDM) | United States | $2.413B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.332B | 20.97 |
| Integra LifeSciences Holdings (IART) | United States | $2.008B | 10.49 |
| Alphatec Holdings (ATEC) | United States | $1.620B | 0.00 |
| RxSight (RXST) | United States | $1.353B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.340B | 0.00 |
| Artivion (AORT) | United States | $1.311B | 86.86 |
| OPKO Health (OPK) | United States | $1.106B | 0.00 |
| Paragon 28 (FNA) | United States | $1.088B | 0.00 |
| AxoGen (AXGN) | United States | $0.807B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.781B | 13.27 |
| IRadimed (IRMD) | United States | $0.778B | 42.03 |
| Mesa Laboratories (MLAB) | United States | $0.770B | 16.83 |
| SiBone (SIBN) | United States | $0.725B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.706B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.640B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.574B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.526B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.521B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.463B | 24.35 |
| AngioDynamics (ANGO) | United States | $0.449B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.438B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.412B | 22.30 |
| NeuroPace (NPCE) | United States | $0.408B | 0.00 |
| CVRx (CVRX) | United States | $0.357B | 0.00 |
| Accuray (ARAY) | United States | $0.277B | 0.00 |
| Inogen (INGN) | United States | $0.258B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.226B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.222B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.222B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.133B | 0.00 |
| LENSAR (LNSR) | United States | $0.126B | 0.00 |
| Hyperfine (HYPR) | United States | $0.125B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.118B | 0.00 |
| Neuronetics (STIM) | United States | $0.108B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.101B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.100B | 15.20 |
| Monogram Orthopaedics (MGRM) | United States | $0.095B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
| 908 Devices (MASS) | United States | $0.089B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.068B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.061B | 31.57 |
| Lucid Diagnostics (LUCD) | United States | $0.057B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.055B | 0.00 |
| Positron (POSC) | United States | $0.053B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.044B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.039B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.037B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.032B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| DarioHealth (DRIO) | United States | $0.021B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |